The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Summary Recent clinical data presented at the Annual Meeting of the American Society of Hematology suggest that rituximab may challenge the role of watch & wait in the management of patients with advanced stage, asymptomatic follicular lymphoma. Other trials confirmed the activity of immuno-chemotherapy, in particular bendamustine plus rituximab, in indolent B-cell lymphomas. A new standard of...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.